J, B., CW, Z., SA, M., L, W., ME, T., AP, F., . . . M, B. (2016). Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. British journal of cancer, 115(1), 12. https://doi.org/10.1038/bjc.2016.146
Chicago Style (17th ed.) CitationJ, Bellmunt, et al. "Association of Tumour MicroRNA Profiling with Outcomes in Patients with Advanced Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy." British Journal of Cancer 115, no. 1 (2016): 12. https://doi.org/10.1038/bjc.2016.146.
MLA (9th ed.) CitationJ, Bellmunt, et al. "Association of Tumour MicroRNA Profiling with Outcomes in Patients with Advanced Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy." British Journal of Cancer, vol. 115, no. 1, 2016, p. 12, https://doi.org/10.1038/bjc.2016.146.